Ask Warren

CreoSG

040350 · KOSDAQ · ₩040350 · 크레오에스지

₩2,515▼ ₩95 (3.64%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −29.07%
Market cap
₩50B
Enterprise value
₩81B
P/E
—
P/B
1.0×
Dividend yield
0.0%
ROE
−6.6%
Net margin
−26.6%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−80.4% from the high

₩2,390Today: ₩2,400 – ₩2,615₩12,800

Returns

  • 1W−9.0%
  • 1M−25.7%
  • 3M−56.8%
  • 6M−31.3%
  • YTD−48.6%
  • 1Y−29.1%
Volume today
49,956
0.8× the 20-day average
Traded today
₩124M
Listed shares
19,856,196
EPS (12 months)
−₩160
Earnings yield −6.3%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Signals

38Quiet
  • BuzzQuietBuzz 38 of 100 (50 is a normal day for this stock).
  • SentimentMixedNews: Routine shareholding filing with no clear positive or negative news. Community: 0 bullish, 0 bearish posts this week.
  • MomentumWeak-26.5% over the last month; the price is below its 20-day average.
  • News impactLow5 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

CreoSG stock overview

CreoSG (크레오에스지, KRX: 040350) is listed on KOSDAQ, in the IT services sector. Creo Group operates through three segments: a solutions business that develops and supplies financial IT software, including the BANCS-K core banking system, to banks and other financial institutions, and also provides IT system construction, maintenance and migration services for customers in auto and apparel distribution and the paper industry; a bio business developing vaccines for AIDS, COVID-19 and other infectious diseases, and super-antibiotics against Staphylococcus aureus, which currently generates no revenue; and a real estate operation business conducted through its subsidiary Creo Estate, which engages in property operation and leasing and management. Its shares closed at ₩2,515 on Oct 29, 2026, down 3.64% on the day, giving it a market value of ₩50B.

Key facts

Market cap
₩50B
Sector
IT services
Latest price change
−3.64%
As of
Oct 29, 2026
Main business
Creo Group operates through three segments: a solutions business that develops and supplies financial IT software, including the BANCS-K core banking system, to banks and other financial institutions, and also provides IT system construction, maintenance and migration services for customers in auto and apparel distribution and the paper industry; a bio business developing vaccines for AIDS, COVID-19 and other infectious diseases, and super-antibiotics against Staphylococcus aureus, which currently generates no revenue; and a real estate operation business conducted through its subsidiary Creo Estate, which engages in property operation and leasing and management.

Quick answers about CreoSG

What does CreoSG do?
Creo Group operates through three segments: a solutions business that develops and supplies financial IT software, including the BANCS-K core banking system, to banks and other financial institutions, and also provides IT system construction, maintenance and migration services for customers in auto and apparel distribution and the paper industry; a bio business developing vaccines for AIDS, COVID-19 and other infectious diseases, and super-antibiotics against Staphylococcus aureus, which currently generates no revenue; and a real estate operation business conducted through its subsidiary Creo Estate, which engages in property operation and leasing and management.
What is the market cap of CreoSG?
The market capitalisation of CreoSG was ₩50B at the close on Oct 29, 2026.
Who are the largest shareholders of CreoSG?
According to the latest official filings, the largest reported holders are Curo Holdings (44.09%, as of Oct 30, 2026); K Partners (10.13%, as of Apr 23, 2026); Lee Sang-gyun (2.72%, as of Apr 23, 2026).
When is the next earnings report from CreoSG?
Korean companies rarely announce results dates in advance. Based on when CreoSG filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

Creo Group operates through three segments: a solutions business that develops and supplies financial IT software, including the BANCS-K core banking system, to banks and other financial institutions, and also provides IT system construction, maintenance and migration services for customers in auto and apparel distribution and the paper industry; a bio business developing vaccines for AIDS, COVID-19 and other infectious diseases, and super-antibiotics against Staphylococcus aureus, which currently generates no revenue; and a real estate operation business conducted through its subsidiary Creo Estate, which engages in property operation and leasing and management.

Written by AI from the company's latest annual report.

Korean name
크레오에스지
Sector
IT services
Themes
—
Business group
QCP
CEO
이상균
Founded
Apr 1997
Listed
Jan 2002
Listed shares
19,856,196
Fiscal year ends
Month 12
Website
www.curocom.com

Similar companies

Recent news

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: CreoSG / 크레오에스지 / 040350 / KRX:040350

Source: KRX statistical information